Aeterna zentaris inc

Major-Pharmaceuticals

AEZS


315 Sigma Drive
Summerville , SC 29486

Executive/
Director

Price

  • Last Close
  • $ 1.95
    $ +0.09 4.84 %
    Apr 22, 2024
  • 52-Week High/Low
  • $2.68 - $1.42
  • YTD
  • 0%

  • Trading Volume
  • 600
  • Market Cap Full
  • $ 9.5M
  • Shares Outstanding
  • 4.9M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -25.9% -16.7% -38.1% 58.2% -5% 176% 2.2% -18.4% 15.1% -
Q2 -1.8% -66.7% 46.6% -43.9% 4% -22.8% -45.7% -1.9% - -
Q3 5.5% 103% -13% -66.8% 8% -14.8% 1815% -5.5% - -
Q4 4.7% 14% 68% -8% 18% -52% -16.5% -21.2% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 -1.1% 5.4% 10.3% -2.3% - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -93%-20%-34%25%-69%-55%-13%789%-42%5%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.37 0.31 0.87 -0.3 0.04 -0.02 -0.5 -0.88
Q2 0.71 0.46 -0.16 0.01 -0.15 -0.02 -0.87 -0.52
Q3 0.61 0.44 - -0.02 -0.02 -0.01 -0.7 -0.85
Q4 0.71 0.24 - -0.04 0.01 -0.49 -2.61 -
A 2.4 1.5 0.7 -0.4 -0.1 -0.5 -4.68 -2.25

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 16.4 20 62.7 121.4 4.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover 0.1 0.1 0.1 0.1 1.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -1.9 9 6 2.5 1.7
Equity multiplier - - - - -